Bevacizumab: Is the lower the better for glioblastoma patients in progression?
Sirven-Villaros L, Bourg V, Suissa L, Mondot L, Almairac F, Fontaine D, Paquis P, Burel-VandenBos F, Frenay M, Thomas P, Lebrun-Frenay C.
Sirven-Villaros L, et al. Among authors: paquis p.
Bull Cancer. 2018 Dec;105(12):1135-1146. doi: 10.1016/j.bulcan.2018.07.010. Epub 2018 Oct 6.
Bull Cancer. 2018.
PMID: 30301554